PerkinElmer: Q1 Earnings Insights

Shares of PerkinElmer PKI increased in after-market trading after the company reported Q1 results.

Quarterly Results

Earnings per share rose 455.22% year over year to $3.72, which beat the estimate of $3.07.

Revenue of $1,308,000,000 up by 100.49% year over year, which beat the estimate of $1,210,000,000.

Guidance

PerkinElmer Sees Q2 Adj. EPS $2.35 vs $2.35 Estimate, Sales ~$1.11B vs $1.07B Est.

How To Listen To The Conference Call

Date: May 04, 2021

Time: 05:00 PM

ET Webcast URL: https://edge.media-server.com/mmc/p/mjujba64

Recent Stock Performance

52-week high: $162.70

Company's 52-week low was at $85.71

Price action over last quarter: Up 1.71%

Company Profile

PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes prenatal screening and infectious-disease testing, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening to environmental analytical tools.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!